Portola Pharmaceuticals (Nasdaq: PTLA) entered into a second clinical collaboration agreement with Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE